- 全部删除
- 您的购物车当前为空
hPL-IN-2 是一种具有有效性、可逆性、和非竞争性胰脂肪酶 (Pancreatic lipase) 抑制剂 (IC50: 1.63 μM),可用于研究肥胖相关疾病。
为众多的药物研发团队赋能,
让新药发现更简单!
hPL-IN-2 是一种具有有效性、可逆性、和非竞争性胰脂肪酶 (Pancreatic lipase) 抑制剂 (IC50: 1.63 μM),可用于研究肥胖相关疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 273 | In stock | |
5 mg | ¥ 648 | In stock | |
10 mg | ¥ 1,070 | In stock | |
25 mg | ¥ 1,780 | In stock | |
50 mg | ¥ 2,620 | In stock | |
100 mg | ¥ 3,700 | In stock | |
200 mg | ¥ 4,930 | In stock |
产品描述 | hPL-IN-2 is a potent, reversible and non-competitive inhibitor of Pancreatic lipase (IC50: 1.63 μM) that can be used to investigate obesity-related diseases. |
靶点活性 | Pancreatic lipase:1.63 μM, PL (human):1.7 μM |
分子量 | 443.11 |
分子式 | C19H11Cl4NO3 |
CAS No. | 24900-61-6 |
Smiles | O=C(NC1=CC=C(OC2=CC=C(Cl)C=C2)C(Cl)=C1)C=3C=C(Cl)C=C(Cl)C3O |
密度 | no data available |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/mL (124.12 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容